We are updating our pages on Lenalidomide (also known as Revlimid) to ensure we’re providing our members with the most up-to-date information on treating MDS with this drug.

Although some patients have reported very positive outcomes with Lenalidomide since it became widely available a few years ago, like with all drug therapies, there are potential side effects to take into consideration. As with any treatment it is strongly recommended that you familiarise yourself with the pros and cons, and talking this through thoroughly with your clinical team.

You might find the following links a useful source of general information about Lenalidomide:

• Macmillan Cancer Support: Lenalidomide (Revlimid®) | Macmillan Cancer Support
• Cancer Research: Lenalidomide (Revlimid) | General cancer information | Cancer Research UK